Literature DB >> 19360371

Intrahepatic micrometastases around liver metastases from gastric cancer.

Takashi Nomura1, Yukinori Kamio, Naoki Takasu, Toshiyuki Moriya, Akiko Takeshita, Masaomi Mizutani, Osamu Hachiya, Ichiro Hirai, Wataru Kimura.   

Abstract

BACKGROUND/
PURPOSE: We aimed to clarify the association between the presence of micrometastases around liver metastases from gastric cancer and the results of hepatic resection. In addition, we investigated the influence of E-cadherin and matrix metalloproteinase (MMP)-7 expression on the development of micrometastases.
METHODS: Micrometastases around liver metastases were examined microscopically in 31 metastatic liver tumor specimens resected from 17 patients who had undergone hepatic resection for liver metastases from gastric cancer. E-cadherin and MMP-7 expression in the primary gastric tumor, the liver metastases, and the micrometastases were examined immunohistochemically.
RESULTS: Hepatic micrometastases were present in around 48% of the liver metastases, accounting for 59% of the patients. The tumor recurrence rate in the remnant liver after hepatic resection was significantly higher, and survival significantly poorer, in patients with such micrometastases than in those without. Micrometastases tended to appear around the liver metastases that had reduced E-cadherin expression. Most of the micrometastases in the lymph ducts and sinusoids showed reduced E-cadherin expression. MMP-7 expression was not correlated with the presence of micrometastases.
CONCLUSIONS: About half of the hepatic metastases from gastric cancer had seeded off micrometastases, and the presence of these micrometastases was associated with a poorer result of hepatic resection. Reduced E-cadherin expression in metastatic liver tumors may be associated with the development of micrometastases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19360371     DOI: 10.1007/s00534-009-0081-y

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  14 in total

1.  MMP-9 is increased in the pathogenesis of gastric cancer by the mediation of HER2.

Authors:  Y-Q Shan; R-C Ying; C-H Zhou; A-K Zhu; J Ye; W Zhu; T-F Ju; H-C Jin
Journal:  Cancer Gene Ther       Date:  2015-01-30       Impact factor: 5.987

2.  Enhanced proliferation, invasion, and epithelial-mesenchymal transition of nicotine-promoted gastric cancer by periostin.

Authors:  Yu Liu; Bao-An Liu
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

3.  Systemic chemotherapy as a main strategy for liver metastases from gastric cancer.

Authors:  W Zhang; Y Yu; Y Fang; Y Wang; Y Cui; K Shen; T Liu
Journal:  Clin Transl Oncol       Date:  2015-06-25       Impact factor: 3.405

Review 4.  Intensified neoadjuvant multimodal approach in synchronous liver metastases from gastric cancer: a single institutional experience.

Authors:  L Ceniceros; A Chopitea; F Pardo; F Rotellar; L Arbea; J J Sola; J C Subtil; B Sangro; A Benito; J L Hernández-Lizoain; J Rodríguez
Journal:  Clin Transl Oncol       Date:  2017-10-17       Impact factor: 3.405

5.  HER-2-induced PI3K signaling pathway was involved in the pathogenesis of gastric cancer.

Authors:  Y F Fu; R Gui; J Liu
Journal:  Cancer Gene Ther       Date:  2015-01-23       Impact factor: 5.987

6.  Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile?

Authors:  Mattia Garancini; Fabio Uggeri; Luca Degrate; Luca Nespoli; Luca Gianotti; Angelo Nespoli; Franco Uggeri; Fabrizio Romano
Journal:  HPB (Oxford)       Date:  2012-03       Impact factor: 3.647

Review 7.  The role of surgery in the therapeutic approach of gastric cancer liver metastases.

Authors:  Aikaterini Mastoraki; Christina Benetou; Sotiria Mastoraki; Ioannis S Papanikolaou; Nikolaos Danias; Vassilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  Indian J Gastroenterol       Date:  2016-08-16

8.  Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer patients with synchronous multiple hepatic metastases: a pilot study.

Authors:  Zi-Yu Li; Lei Tang; Lian-Hai Zhang; Zhao-De Bu; Ai-Wen Wu; Xiao-Jiang Wu; Xiang-Long Zong; Qi Wu; Fei Shan; Shuang-Xi Li; Hui Ren; Xiao-Peng Zhang; Jia-Fu Ji
Journal:  Med Oncol       Date:  2009-12-05       Impact factor: 3.064

Review 9.  Surgical treatment of liver metastases of gastric cancer: state of the art.

Authors:  Fabrizio Romano; Mattia Garancini; Fabio Uggeri; Luca Degrate; Luca Nespoli; Luca Gianotti; Angelo Nespoli; Franco Uggeri
Journal:  World J Surg Oncol       Date:  2012-08-03       Impact factor: 2.754

10.  Upregulation of nucleostemin in colorectal cancer and its effects on cell malignancy.

Authors:  Bin Wei; Qiaoying Huang; Xiaogang Zhong
Journal:  Onco Targets Ther       Date:  2015-07-21       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.